Indianz.Com > COVID-19 > Indian Health Service (Department of Health and Human Services)
https://wp.me/pbXgss-4mL
Posted: January 19, 2022
ihscovid19vaccine

Image: Indian Health Service

The Indian Health Service has updated its coronavirus data, showing COVID-19 vaccination distribution and administration as of January 18, 2022.

According to the data, the IHS has distributed 2,667,930 COVID-19 vaccine doses across 11 areas of Indian Country. Of that amount, 2,077,488 have been administered, representing nearly 78.8 percent of the total.

The number of vaccines distributed by the IHS increased by almost 2.5 percent, according to a comparison of data from January 10. Meanwhile, the number of vaccines administered grew by nearly 1.3 percent when compared to the week prior.

The Oklahoma City Area, where COVID-19 cases increased considerably following the availability of the vaccine in the spring of 2020, continues to account for the most vaccines received (640,865) and administered (497,937). The Navajo Area, where the pandemic has exacted a disproportionate toll since the spring of 2020, comes in second (389,880 distributed, 357,483 administered) while the California Area comes in third (319,930 distributed, 207,406 administered).

In all three areas, the number of doses administered, as well as the number of doses distributed, increased from the week prior. The three regions account for the largest number of IHS users, with the Phoenix Area also accounting for a large number (287,605 distributed, 236,859 administered). The Phoenix Area has been disproportionately affected by COVID-19 as well.

According to the IHS, vaccination distribution and administration will be updated weekly across the 11 areas that are receiving doses directly from the agency. However, data does not appear to have been released in the week immediately preceding the Christmas holiday.

Tribal health facilities in Alaska have chosen to receive their COVID-19 vaccine supplies from the state, so their region is not included in the data.

COVID-19 Vaccine Distribution and Administration by IHS Area

As of January 18, 2022, the IHS is distributing all three COVID-19 vaccines currently authorized or approved in the U.S, including Pfizer-BioNTech, Moderna, and Janssen/Johnson & Johnson. The table below shows the total number of vaccine doses distributed and administered to date, per IHS Area, for facilities that chose to receive vaccine through the IHS jurisdiction. The data includes COVID-19 vaccinations administered to all ages and specialty groups authorized for emergency use or fully licensed by the Food and Drug Administration (FDA). The IHS administration rate is 78 percent. The IHS jurisdiction is administering all available full doses in accordance with FDA guidance.

Area Total Doses Distributed* Total Doses Administered**
Albuquerque 182,390 175,846
Bemidji 217,320 166,213
Billings 116,430 73,042
California 319,930 207,406
Great Plains 209,530 145,031
Nashville 143,040 102,351
Navajo 389,880 357,483
Oklahoma City 640,865 497,937
Phoenix 287,605 236,859
Portland 145,250 103,694
Tucson 15,690 11,626
Grand Total 2,667,930 2,077,488

*Distributed Data Source: IHS National Supply Service Center, includes total doses ordered and delivered by January 14, 2022, to facilities that chose the IHS jurisdiction for vaccine distribution.

**Administered Data Source: Data is reported from the Vaccine Administration Management System (VAMS) and IHS Central Aggregator Service (CAS). Data may be different than data on the CDC COVID-19 Vaccine Tracker due to lags and ongoing quality review of data, including resolving data errors.

Note:The COVID-19 Vaccine Distribution and Administration by IHS Area data is only reflective of facilities that chose the IHS jurisdiction for vaccine distribution. Alaska Area data is not reported as all tribes chose to receive COVID-19 vaccine from the State of Alaska. The Tucson Area data only includes one tribe that chose the IHS jurisdiction for vaccine distribution.

Source: Indian Health Service (https://www.ihs.gov/coronavirus)

Join the Conversation